Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

When caught early, skin cancer is highly treatable. Find out if there is a free skin cancer check near you by using the map below. Clicking on your state will show you the scheduled free skin cancer ...